cmAngio® vs eMurmur Heart AI
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your primary goal is to leverage existing mammography data for early cardiovascular risk assessment in women. This tool is ideal for radiology departments and women's health centers looking to identify Breast Arterial Calcifications (BAC) as a biomarker for cardiovascular health without additional procedures or radiation, seamlessly integrating into routine breast screening workflows.
View cmAngio® →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if you need an AI-powered solution for automated analysis of heart and lung sounds to detect murmurs and gain hemodynamic insights. This tool is particularly well-suited for clinicians seeking to enhance physical examinations, facilitate remote patient monitoring via telehealth, or improve the consistency and accuracy of auscultation across various care settings.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | eMurmur Heart AI |
|---|---|---|
| Pricing | Paid, out-of-pocket | Contact for quote |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | Web-based, Mobile App, API integration |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers greater flexibility and accessibility with its mobile app, web portal, and hardware-neutral compatibility, making it adaptable to diverse clinical environments and telehealth workflows. While cmAngio focuses on seamless integration into radiology workflows, eMurmur's broader platform support caters to a wider range of users and use cases.
Clinical Value
eMurmur Heart AIeMurmur Heart AI directly enhances a fundamental diagnostic procedure (auscultation) by providing objective, AI-powered analysis of heart and lung sounds, including hemodynamic insights, which can significantly improve the accuracy of murmur detection and support earlier intervention. While cmAngio offers valuable secondary insights from existing mammograms, eMurmur directly addresses a primary diagnostic challenge with a high degree of reported accuracy.
Pricing & Value
eMurmur Heart AIWhile both require contacting the vendor for specific pricing, eMurmur Heart AI offers a more transparent approach with mentions of 'Freemium with subscription for full features' and different 'Basic, Pro, Telehealth and Enterprise levels,' along with a 'Free 30-day trial.' This provides potential users with more insight into possible cost structures and an opportunity to evaluate the tool before commitment, unlike cmAngio's less detailed 'limited-time offers for no-cost implementation and service.'
Enterprise Readiness
eMurmur Heart AIeMurmur Heart AI explicitly states that a Business Associate Agreement (BAA) is available, which is a critical component for enterprise deployments handling Protected Health Information (PHI). While cmAngio is HIPAA-compliant and cybersecure, its BAA availability is less definitive ('contact vendor for details'). Additionally, eMurmur's broader deployment options (cloud, web, mobile) offer more flexibility for integration into diverse enterprise IT infrastructures and telehealth strategies.
Innovation
TieBoth tools demonstrate significant innovation in their respective fields. cmAngio innovatively extracts new, critical cardiovascular risk information from routine mammograms, effectively adding a new layer of screening without additional patient burden. eMurmur Heart AI revolutionizes the centuries-old practice of auscultation by making it objective, AI-driven, and adaptable for modern telehealth, offering detailed heart and lung sound analysis and hemodynamic insights. Both represent substantial advancements in healthcare AI.
Support & Docs
eMurmur Heart AIeMurmur Heart AI provides more explicit indications of support and educational resources, including a 'Free 30-day trial' with an offer for 'additional assistance with teaching or training' and the 'Littmannu00ae Learning App' for auscultation education. While CureMetrix offers contact information and mentions an operator's manual, eMurmur's proactive approach to training and educational content suggests a more robust support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | eMurmur Heart AI |
|---|---|---|
| Name | cmAngiou00ae | eMurmur Heart AI |
| Company | CureMetrix | CSD Labs |
| Description | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings. |
| Primary Function | AI-based detection of Breast Arterial Calcifications (BAC) on mammograms | Automated heart and lung sound analysis for murmur detection and hemodynamic insights |
| Specialties | Cardiology, Obstetrics & Gynecology, Radiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and eMurmur Heart AI.